磷脂酰丝氨酸
安慰剂
认知障碍
疾病
阿尔茨海默病
医学
认知
内科学
精神科
病理
生物
生物化学
膜
替代医学
磷脂
作者
Thomas H. Crook,William M. Petrie,Charles D. Wells,D. Massari
出处
期刊:PubMed
日期:1992-01-01
卷期号:28 (1): 61-6
被引量:103
摘要
We studied 51 patients meeting clinical criteria for probable Alzheimer's disease (AD). Patients were treated for 12 weeks with a formulation of bovine cortex phosphatidylserine (BC-PS; 100 mg t.i.d.) or placebo, and those treated with the drug improved on several cognitive measures relative to those administered placebo. Differences between treatment groups were most apparent among patients with less severe cognitive impairment. Results suggest that phosphatidylserine may be a promising candidate for study in the early stages of AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI